Meridian Health Ventures

Meridian Health Ventures is a London-based investment firm operating as the first transatlantic health tech fund. The firm focuses on investing in clinical innovators across Digital Health and MedTech, aiming to enable the adoption of transformative solutions at scale. They specialize in helping ambitious founders and health tech ventures to thrive domestically in the UK while accelerating their growth in the US. The firm collaborates with health system partners and its portfolio companies to generate real-world data and evidence, which is crucial for broader adoption of their solutions.

Originally launched in 2021 as KHP Ventures, Meridian Health Ventures was established through a partnership involving General Catalyst, Speedinvest, and several NHS trusts, including Guy's and St Thomas', King's College Hospital, and University College London Hospitals, alongside US hospital groups Cedars-Sinai Medical Center and Hartford HealthCare. The firm's unique value-adding model emphasizes building solutions with patients, professionals, and health systems from the outset, creating alignment and supporting key milestones for its portfolio companies. In October 2024, Meridian Health Ventures further expanded its thematic investing by launching Europe's first dedicated mental health tech fund, the Innovations in Mental Health (IMH) Fund, in partnership with the Wellcome Trust and South London and Maudsley NHS Trust.

The firm's portfolio includes a range of fast-growing health tech companies such as Apian, 52 North, Doccla, deepc, Patchwork, Tympa Health, iFAST Diagnostics, PocDoc, Phare Health, MediShout, and Klaris. These companies have collectively deployed solutions in numerous NHS Trusts and are expanding their presence in major US healthcare providers. Meridian Health Ventures provides practical, hands-on support, including connectivity to key NHS stakeholders, guidance on building robust evidence for innovations, and connections to health systems in both the UK and the US.

Meridian Health Ventures is managed by a team of experienced health tech operators and clinical entrepreneurs who have transitioned into early-stage investors. The team, including Co-Managing Partners Dr. Nadine Haram and Daniel Dickens, and General Partners Dr. Pooja Sikka and Tim Irish, brings a diverse background spanning venture capital investment, finance, legal and regulatory expertise, clinical practice and research, NHS operations, and health policy. This blend of clinical and investment experience allows them to identify and support promising founders in healthcare effectively.